PBM 2.58 ▼ -2.64% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Psyence Biomedical Ltd.

    NASDAQ: PBM · Real-Time Price · USD
    2.58
    -0.07 (-2.64%)
    At close: Sep 04, 2025, 3:59 PM
    2.58
    -0.02%
    After-hours: Sep 04, 2025, 07:55 PM EDT
    -2.64%
    Bid 2.51
    Market Cap 1.84M
    Revenue (ttm) n/a
    Net Income (ttm) -25.33M
    EPS (ttm) 41.76
    PE Ratio (ttm) 0.06
    Forward PE n/a
    Analyst n/a
    Ask 2.67
    Volume 89,953
    Avg. Volume (20D) 1,662,309
    Open 2.63
    Previous Close 2.65
    Day's Range 2.48 - 2.67
    52-Week Range 2.36 - 146.40
    Beta 0.18

    About PBM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PBM
    Website n/a
    Full Company Profile
    1 month ago
    -6.85%
    PBM stock has given up its prior gain. Psyence Bio... Unlock content with Pro Subscription
    1 month ago
    -6.85%
    Psyence Biomedical shares are trading higher after the company announced it, along with PsyLabs, achieved a breakthrough in GMP-aligned high-purity ibogaine production.
    news image

    1 month ago · newsfilecorp.com

    Pacific Bay Warrant Extension Not Proceeding

    Vancouver, British Columbia--(Newsfile Corp. - August 1, 2025) - Reagan Glazier, President & CEO, Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or, the "Company") reports that the proposed exte...

    news image

    1 month ago · zacks.com

    CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?

    CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

    news image

    2 months ago · newsfilecorp.com

    Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025

    Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) Denver, Colorado--(Ne...

    news image

    2 months ago · newsfilecorp.com

    Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements

    New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasda...

    Add to Watchlist